Location History:
- Mercerville, NJ (US) (2008)
- Carlsbad, CA (US) (2008)
Company Filing History:
2 out of 3,684 
2 out of 2,963 
Years Active: 2008
Title: The Innovative Contributions of Bruce L. Jacobson
Introduction
Bruce L. Jacobson, an accomplished inventor based in Mercerville, NJ, has made significant contributions to the fields of diabetes and atherosclerosis treatment through his innovative patents. With two patents to his name, Jacobson's work demonstrates a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Jacobson's latest patents include a novel method for treating diabetes utilizing an aP2 inhibitor as well as a combination approach with established antidiabetic agents such as metformin, glyburide, troglitazone, and insulin. This method offers new hope for managing Type II diabetes. Additionally, he has patented a method for treating atherosclerosis that employs an aP2 inhibitor or its combination with antiatherosclerotic agents, specifically HMG CoA reductase inhibitors like pravastatin. These inventions showcase Jacobson's innovative approach to addressing critical health issues.
Career Highlights
Throughout his career, Bruce L. Jacobson has worked with notable organizations, most prominently Bristol-Myers Squibb Company and the President and Fellows of Harvard College. His experience in these esteemed institutions has allowed him to refine his research and contribute effectively to the development of groundbreaking medical therapies.
Collaborations
Jacobson has collaborated with esteemed colleagues, including Jeffrey A. Robl and Rex A. Parker. These partnerships have facilitated the exchange of ideas and advancements in his research endeavors, further strengthening the impact of his work in the medical field.
Conclusion
In summary, Bruce L. Jacobson's innovative contributions through his patents exemplify the potential of targeted therapies in treating complex health conditions. His dedication to research and collaboration with distinguished organizations and colleagues places him among the leading innovators in his field, showcasing the importance of innovation in advancing healthcare solutions.